Zymeworks (ZYME) Other Working Capital Changes (2021 - 2026)
Zymeworks (ZYME) reported Other Working Capital Changes of -$340000.0 for Q1 2026, up 83.76% on a YoY basis from -$185028.6 in Q1 2025, and up 56.35% sequentially from -$779000.0 in Q4 2025.
Zymeworks (ZYME) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 4 years of Other Working Capital Changes data on file, last reported at -$340000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 83.76% year-over-year to -$340000.0; the trailing twelve-month figure through Mar 2026 stood at -$21.4 million (down 1344.45% YoY), and the FY2025 full-year result was -$23.2 million, down 751.76% from the prior year.
- Other Working Capital Changes improved to -$340000.0 in Q1 2026, from -$779000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $10.0 million in Q4 2024 to a low of -$18.0 million in Q3 2023.
- A 5-year average of -$544529.4 and a median of -$648000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes jumped 121.76% in 2024 and sank 1046.35% in 2025, its largest moves.
- Tracing ZYME's Other Working Capital Changes over 4 years: stood at $3.6 million in 2023, then sank by 144.34% to -$1.6 million in 2024, then jumped by 51.28% to -$779000.0 in 2025, then jumped by 56.35% to -$340000.0 in 2026.
- Business Quant data shows ZYME's Other Working Capital Changes at -$340000.0 in Q1 2026, -$779000.0 in Q4 2025, and -$614000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -838,000.00 |
| Dec 31, 2025 | -838,000.00 |
| Dec 31, 2025 | -838,000.00 |
| Sep 30, 2025 | -872,000.00 |
| Sep 30, 2025 | -872,000.00 |
| Sep 30, 2025 | -872,000.00 |
| Jun 30, 2025 | -818,000.00 |
| Jun 30, 2025 | -818,000.00 |
| Jun 30, 2025 | -818,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Mar 31, 2025 | -814,000.00 |
| Dec 31, 2024 | 10.02 Mn |
| Dec 31, 2024 | 10.02 Mn |
| Dec 31, 2024 | 10.02 Mn |
| Sep 30, 2024 | -11.25 Mn |
| Sep 30, 2024 | -11.25 Mn |